About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Postpartum Screening of Type 2 Diabetes

NCT01869608·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Université de Sherbrooke

With

The Lawson Foundation

Age

18–45

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Women aged between 18 and 45 years;
Having a positive diagnosis of gestational diabetes mellitus (IADPSG criteria);
Treated with diet or insulin;
Have given birth to a child at term; gestational age \> 37 weeks;
Have been followed during her pregnancy by a physician who delivers in CHUS;
Have signed the consent form.

You may not be if

History of glucose intolerance or diabetes before the pregnancy;
Have presented another obstetrical pathology during the pregnancy;
* Severe gestational high blood pressure with proteinuria;
* Delayed intrauterine development syndrome;
* Pregnancy with more than a foetus;
* Drug addiction;
* Had complications during the delivery such as:
Moderate to severe postpartum bleeding;
Surgery in postpartum (curettage, hysterectomy, etc.).

The record

StatusCompleted

PhaseNo phase

Taking part121

StartedApr 2014

UpdatedMay 1, 2019

Conditions

Type 2 Diabetes

Where1

Clinical Research Center Étienne-Le Bel of the Sherbrooke University Hospital
Sherbrooke, Quebec, Canada

Clareo Health | Postpartum Screening of Type 2 Diabetes